Home/Filings/4/0001415889-23-000099
4//SEC Filing

VASCONCELLES MICHAEL 4

Accession 0001415889-23-000099

CIK 0000855654other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:17 PM ET

Size

5.5 KB

Accession

0001415889-23-000099

Insider Transaction Report

Form 4
Period: 2022-12-29
VASCONCELLES MICHAEL
EVP R&D & MEDICAL AFFAIRS
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-29+960,000960,000 total
    Exercise: $5.16Exp: 2032-12-29Common Stock (960,000 underlying)
Footnotes (1)
  • [F1]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001734755

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:17 PM ET
Size
5.5 KB